Weakness in patients with triple-A may be related to factors such as impaired liver function, decreased autoimmune function and vitamin E deficiency, which are treated with targeted medications according to the cause of the disease. 1. Impaired liver function: it will affect the normal liver function, and the metabolic function of the liver will be abnormal, which will affect the nerve conduction mediators and lead to weakness. Glycyrrhizin tablets can be used for treatment as prescribed by the doctor, which has anti-inflammatory, anti-allergic and immunomodulatory effects, improves the abnormalities of liver function, and thus relieves the symptoms of weakness. 2. Decreased autoimmune function: Due to the low immunity of hepatitis B teratitis III patients, they are susceptible to bacterial infections and wind-cold flu, which may also lead to weakness. You can use transaminase capsules for treatment, which are used as anti-infection drugs to regulate the immune system, thus improving the symptoms of weakness. 3. Vitamin E deficiency: Vitamin E deficiency in patients with triple A can cause an increase in muscle oxygen consumption, resulting in muscular dystrophy and generalized weakness, which can be treated with vitamin E capsules. Vitamin E belongs to the antioxidant, involved in the body’s metabolic reactions, can fight against free radical oxidation, so as to improve the symptoms of weakness. Patients with springtime weakness in patients with greater than three suns should go to the hospital and follow the doctor’s instructions for regular treatment.